profit from every $100 of sales.
$0$100
Kenvue
$19.31-1.28% today
+20.9% in 1 year
1-year low $15.971-year high $19.88
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2025.
0%20% a year
You pay $25.24 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Kenvue sold, what it kept, and what it did with the cash.
Sales went from $15.0 billion in 2022 to $15.1 billion in 2025, with $1.47 billion of profit last year.
SalesProfit
Kenvue handed back more cash to shareholders than it generated last year.
$1.6B
Free cash flow 2025$1.7B
Bought back its own shares$197M
Paid as dividends$1.6B
Cash vs. debt$1.1B vs. $8.7B
Kenvue vs. similar companies
Kenvue grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Kenvue | 25.2× · Fair price | ||
 Procter & Gamble | 24.2× · Fair price | ||
 L'Oréal | 38.9× · Expensive | ||
 Unilever | 13.5× · Cheap | ||
 Colgate-Palmolive | 36.5× · Expensive |
AI analysis
An AI analyst reads Kenvue's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 15,054 | 14,950 | 15,444 | 15,455 | 15,124 | |
| 8,419 | 8,285 | 8,643 | 8,959 | 8,792 | |
| – | 2,688 | 2,493 | 2,629 | 2,715 | |
| 3,651 | 3,281 | 3,175 | 2,468 | 2,986 | |
| 2,078 | 2,064 | 1,664 | 1,030 | 1,470 | |
| 1.21 | 1.09 | 0.90 | 0.54 | 0.76 | |
| 55.9% | 55.4% | 56.0% | 58.0% | 58.1% | |
| – | 18.0% | 16.1% | 17.0% | 18.0% | |
| 13.8% | 13.8% | 10.8% | 6.7% | 9.7% |
Balance sheet
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | – | 27,316 | 27,851 | 25,601 | 27,076 |
| Cash | 740 | 1,231 | 1,382 | 1,070 | 1,062 |
| Total debt | – | 116 | 8,427 | 8,720 | 8,674 |
| Total liabilities | – | 7,346 | 16,640 | 15,933 | 16,311 |
| 20,491 | 19,970 | 11,211 | 9,668 | 10,765 | |
| 1,716 | 1,889 | 1,850 | 1,923 | 1,924 | |
| 11.3% | 10.4% | 10.3% | 7.9% | 9.9% | |
| 10.1% | 10.3% | 14.8% | 10.7% | 13.7% |
Cash flow
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 334 | 2,525 | 3,168 | 1,769 | 2,197 | |
| 295 | 375 | 469 | 434 | 475 | |
| 39 | 2,150 | 2,699 | 1,335 | 1,722 | |
| Dividends paid | 0 | 0 | 14,554 | 1,552 | 1,581 |
| – | 0 | 7 | 235 | 197 | |
| 141 | 137 | 188 | 254 | 136 |
Valuation
- 25.2×
- 17.0×
- –
- 3.1×
- 2.5×
- 21.6×
- 15.0×
- 4.6%
- 4.0%
- 4.8%
Profitability
- 58.1%
- 18.0%
- 9.7%
- 19.6%
- 9.8%
- 7.8%
- 13.9%
- 5.4%
- 12.8%
- –
Growth
- +0.1%
- −11.0%
- +29.0%
- –
- +0.4%
Financial health
- 2.3×
- 0.82
- 31.5%
- 6.7×
- 0.98
- 0.68
- 0.56
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 49%of 670
Top 22%of 674
Bottom 29%of 624
Bottom 20%of 673
Bottom 48%of 668
What analysts expect
- Average price target
- $18.25
- Range
- $18.00 – $19.00
- 3 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 0.32 | 0.27 | +18.5% |
| Feb 17, 2026 | 0.27 | 0.22 | +21.2% |
| Nov 3, 2025 | 0.28 | 0.26 | +7.6% |
| Aug 7, 2025 | 0.29 | 0.28 | +2.9% |
| May 8, 2025 | 0.24 | 0.23 | +5.5% |
| Feb 6, 2025 | 0.26 | 0.26 | +0.0% |
| Nov 7, 2024 | 0.28 | 0.27 | +2.8% |
| Aug 6, 2024 | 0.32 | 0.28 | +16.1% |
4.8%of the share price, paid each year
On $1,000 invested$48a year at today's yield, before tax
–per share
Raised2 yearsin a row, in our data
Paid per share, each year
$0.40 in 2023 → $0.83 in 2025
How safe it looks
107.6% of its profit
Room to growStretchedMore than it earns: 91.8%
News
Kimberly-Clark Acquires Kenvue. Here’s What Investors Need to Know Ahead of Its Nov. 5 Earnings Report.Yahoo Finance · Nov 3, 2026Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?Yahoo Finance · Sep 18, 2026Kimberly-Clark expected to win EU approval for Kenvue in phase 1 - reportSeeking Alpha · Sep 15, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
50No pass
Benjamin Graham
44No pass
Philip Fisher
46No pass
Peter Lynch
22No pass
Joel Greenblatt
30No pass
Charlie Munger
40No pass
Terry Smith
41No pass
Questions about Kenvue
Is Kenvue a good stock to buy?
A solid business at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Kenvue AI analysis
What does Kenvue do?
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. It is in Household & Personal Products, based in Summit, NJ, United States, with 21,780 employees.
Does Kenvue pay a dividend?
Yes. At today's price the dividend is 4.8% a year, about 108% of its yearly profit. In 2025 it paid out $1.58 billion in dividends.
Is Kenvue stock halal?
Yes. Kenvue passes our halal screen: its business is permitted and its debt is 23% of its market value, under the 30% limit. How we check
How has Kenvue stock done over the past year?
Up 20.9% over the past twelve months, to $19.31. It traded between $15.97 and $19.88 and is 2.9% below its high.
Who are Kenvue's competitors?
The largest listed companies in the same industry are Procter & Gamble, L'Oréal, Unilever and Colgate-Palmolive. The peers table on this page compares their profit, growth and price with Kenvue's.
Prices: daily closes to Oct 30, 2026. Fundamentals: company reports via invest-like data.